OVERVIEW

Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 1/8/2021
Valid for credit through: 1/8/2022

Accreditation:
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Goal Statement:
The goal of this activity is to improve clinicians’ ability to detect and diagnose neurotrophic keratitis (NK) in at-risk populations and aid in the adoption of new targeted treatment options into clinical practice.

Upon completion of this activity, participants will:
• Have increased knowledge regarding the
? Detection, diagnosis, and staging of NK
? New and emerging therapies for NK
• Have greater competence related to
? Selecting the best treatment regimen for NK